Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-25-153417
Filing Date
2025-07-01
Accepted
2025-07-01 06:55:16
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 d830897ds3.htm S-3 183535
2 EX-5.1 d830897dex51.htm EX-5.1 4844
3 EX-23.1 d830897dex231.htm EX-23.1 1853
4 EX-FILING FEES d830897dexfilingfees.htm EX-FILING FEES 29534
5 GRAPHIC g830897g68z39.jpg GRAPHIC 42334
  Complete submission text file 0001193125-25-153417.txt   279140
Mailing Address 99 HIGH STREET SUITE 2100 BOSTON MA 02110
Business Address 99 HIGH STREET SUITE 2100 BOSTON MA 02110 857-321-8020
Rapport Therapeutics, Inc. (Filer) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-288445 | Film No.: 251094139
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)